Cassava Sciences Inc (SAVA)

[declaes]

PTIE was 3$ just before the FDA did not approve remoxy and asked for some extra tests. At the end of 2017 PTIE will be in the same position but with the info FDA asked for. So PTIE will at least get back to that 3 dollar beceause they are in better papers than they where last time. 3$ x 7 is 21$ post rs. If they get approval. PTIE will hit at least 10$ or 70$ post. If by then there hasn't been a buyout, as they said they are in talk with more then 1 party.